DNMT3A and acute myeloid leukemia: The mutation site of DNMT3A in AML differs from other hematologic malignancies, approximately 60% with a specific hotspot point mutation at arginine 882 (R882) at the dimerization interface, most often converted to histidine or cytosine [46, 47].